Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of fulvestrant with or without PD-0332991 (palbociclib) +/- goserelin in women with hormone receptor-positive, HER2-negative metastatic breast cancer (MBC) whose disease progressed after prior endocrine therapy
Turner, N; Andre, F; Loibl, S; Ro, J; Iwata, H; Harbeck, N; Glueck, S; Verma, S; Loi, S; Bartlett, CH; Thiele, A; Zhang, K; Koehler, M; Cristofanilli, M
| HERO ID | 6322155 |
|---|---|
| In Press | No |
| Year | 2013 |
| Title | Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of fulvestrant with or without PD-0332991 (palbociclib) +/- goserelin in women with hormone receptor-positive, HER2-negative metastatic breast cancer (MBC) whose disease progressed after prior endocrine therapy |
| Authors | Turner, N; Andre, F; Loibl, S; Ro, J; Iwata, H; Harbeck, N; Glueck, S; Verma, S; Loi, S; Bartlett, CH; Thiele, A; Zhang, K; Koehler, M; Cristofanilli, M |
| Journal | Cancer Research |
| Volume | 73 |
| Doi | 10.1158/0008-5472.SABCS13-T3-2-10 |
| Wosid | WOS:000209496900098 |
| Is Certified Translation | No |
| Dupe Override | No |
| Is Public | Yes |